Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;227(3):407-411.
doi: 10.1093/infdis/jiac459.

Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared

Kalongo Hamusonde  1   2 , Dunja Nicca  3 , Huldrych F Gnthard  4   5 , Marcel Stckle  6 , Katharine E A Darling  7 , Alexandra Calmy  8 , Enos Bernasconi  9 , David Haerry  10 , Patrick Schmid  3 , Roger D Kouyos  4   5 , Andri Rauch  1 , Luisa Salazar-Vizcaya  1 ; Swiss HIV Cohort Study
Collaborators, Affiliations

Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared

Kalongo Hamusonde et al. J Infect Dis. .

Abstract

We assessed changes in sexual behavior among people with human immunodeficiency virus (HIV) over 20 years. Condom use with stable partners steadily declined from over 90 to 29 since the Swiss U U statement, with similar trajectories between men who have sex with men (MSM) and heterosexuals. Occasional partnership remained higher among MSM compared to heterosexuals even during coronavirus disease 2019 (COVID-19) social distancing.

Keywords: HIV; MSM; Swiss statement; heterosexual; sexual behavior.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest . K. E. A. D.’s institution has received research funding unrelated to this publication from Gilead; and offered expert testimony for MSD. A. R. reports support to his institution for advisory boards and/or travel grants from MSD, Gilead Sciences, Pfizer, and Abbvie; and an investigator initiated trial grant from Gilead Sciences. All remuneration went to his home institution and not to A. R. personally, and all remuneration was provided outside the submitted work. H. F. G. has received unrestricted research grants from Gilead Sciences; fees for data and safety monitoring board membership from Merck; consulting/advisory board membership fees from Gilead Sciences, Merck, Johnson and Johnson, Novartis, and ViiV Healthcare; and grants from the Swiss National Science Foundation, the Yvonne Jacob Foundation, and National Institutes of Health. The institution of E. B. has received grants from the Swiss National Science Foundation; consulting/advisory board membership fees from Gilead Sciences, Merck Sharp and Dohme, ViiV Healthcare, Pfizer, and Lilly; and travel grants from Gilead Sciences, ViiV Healthcare, Pfizer, and Abbvie. All other authors report no potential conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Trajectories and rate of change in consistent condom use and occasional partnership stratified by sexual orientation. A, Consistent condom use with HIV-negative stable partners in MSM and HET, registration year before 2008. B, Rate of change in consistent condom use with HIV-negative stable partner following the trigger. C, Consistent condom use with HIV-positive stable partners in MSM and HET, registration year before 2008. D, Rate of change in consistent condom use with HIV-positive stable partner following the trigger. E, Occasional partners in MSM and HET, registration year before 2020. F, Percent change in occasional sex partners following the trigger. Shaded region, 95% confidence intervals. Abbreviations: COVID-19, coronavirus disease 2019; HET, heterosexual; HIV, human immunodeficiency virus; MSM, men who have sex with men.
See this image and copyright information in PMC

References

    1. Chen YH, Snowden JM, McFarland W, Raymond HF. Pre-exposure prophylaxis (PrEP) use, seroadaptation, and sexual behavior among men who have sex with men, San Francisco, 2004–2014. AIDS Behav 2016; 20:2791–7. - PubMed
    1. Hasse B, Ledergerber B, Hirschel B, et al. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314–22. - PubMed
    1. Rodger AJ, Cambiano V, Phillips AN, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 393:2428–38. - PMC - PubMed
    1. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives nesouffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisse 2008; 89:165–9.
    1. Cohen MS, McCauley M, Gamble TR. HIV Treatment as prevention and HPTN 052. Curr Opin HIV AIDS 2012; 7:99–105. - PMC - PubMed

Publication types